Central to this discovery is the observation that the mitochondrial electron transport chain (ETC), a key player in cellular energy generation, exerts an unexpected protective effect on the NE when its activity is experimentally reduced. Using the model organism Caenorhabditis elegans, a nematode widely used in ageing research, scientists demonstrated that suppressed ETC activity during development preserves NE morphology well into adulthood. This preservation counteracts the natural structural degradation typically seen with age, suggesting that mitochondrial function influences nuclear architecture via mechanisms beyond mere bioenergetics.

The linchpin of this protective effect is mitochondrial superoxide, a reactive oxygen species (ROS) traditionally viewed as harmful byproducts of cellular respiration. Contrary to the prevailing dogma that ROS invariably promote cellular damage and senescence, the researchers reveal a nuanced role for mitochondrial superoxide produced during developmental stages. This superoxide serves as a signaling molecule that triggers downstream pathways modulating lipid metabolism, rather than engendering oxidative damage. Such developmental ‘programming’ reorients cellular lipid biosynthesis trajectories, specifically downregulating SBP-1, an orthologue of the mammalian SREBP—a master transcriptional regulator of lipid synthesis.

SBP-1 suppression leads to a marked reduction in the biosynthesis of unsaturated fatty acids (UFAs), crucial components of cell membranes but also prone to lipid peroxidation, a damaging oxidative modification. By limiting the pool of UFAs, the mitochondria-to-NE axis effectively curtails lipid peroxidation within the nuclear envelope, thereby preserving its structural integrity. This finding intricately connects redox biology and lipid metabolism, highlighting how redox-dependent lipid regulation safeguards nuclear architecture against age-associated deterioration.

The implications of this crosstalk are profound, extending beyond C. elegans to mammalian systems. Therapeutic interventions engineered to modulate lipid peroxidation produced strikingly similar benefits in human fibroblasts and primate cells, particularly in models mimicking Hutchinson-Gilford progeria syndrome (HGPS), a fatal premature ageing disorder marked by severe nuclear envelope abnormalities. By controlling lipid peroxidation chemically or genetically, researchers were able to restore NE integrity, reduce senescent phenotypes, and extend cellular healthspan. These results lay the groundwork for translational approaches targeting ageing-associated nuclear defects in human health.

This research overturns conventional perceptions of mitochondrial superoxide as a byproduct solely detrimental to cell longevity. Instead, it assumes the role of a critical developmental signal that ‘programs’ long-term nuclear envelope maintenance and cellular resilience. It infers that the timing and context of ROS generation are crucial determinants of their biological consequences—a paradigm shift that underscores the complexity of redox signaling in ageing biology.

Moreover, the downregulation of the sterol regulatory element-binding protein orthologue SBP-1 and the concomitant suppression of unsaturated fatty acid biosynthesis pinpoint lipid metabolism as a vulnerable yet modifiable axis in NE maintenance. Unsaturated fatty acids, though essential for membrane fluidity and function, are highly susceptible to oxidative damage; hence, their metabolic regulation emerges as a double-edged sword balancing membrane integrity against oxidative vulnerability.

The detailed mechanistic insights from this study delineate a feedback system whereby mitochondrial redox status communicates with nuclear lipid pathways to fine-tune the biophysical properties of the nuclear envelope. Such a system ensures that membrane lipid compositions favor resistance to peroxidative damage—a critical attribute for maintaining nuclear barrier functions and genome stability during ageing.

Technological advances underpinning this discovery included high-resolution imaging to monitor nuclear envelope architecture, combined with genetic manipulations and biochemical assays in both nematode and mammalian cell models. These approaches allowed meticulous dissection of the interplay between mitochondrial ROS dynamics and lipid metabolic fluxes. The conserved nature of these pathways between species emphasizes a fundamental evolutionary mechanism for cellular longevity.

The therapeutic promise arising from these findings is considerable. Targeting lipid peroxidation through pharmacological agents or dietary modulation could mitigate age-related nuclear envelope decline and potentially delay the progression of degenerative disorders characterized by nuclear dysmorphia. The study opens avenues for novel anti-ageing interventions that harness endogenous mitochondrial signaling rather than indiscriminately scavenging reactive oxygen species.

Furthermore, this study challenges the broad-brush use of antioxidants in ageing medicine. Instead, it advocates for precision modulation of redox signaling pathways to harness the beneficial signaling roles of ROS like mitochondrial superoxide while minimizing their pathological effects. Tailoring redox-lipid interactions represents a dynamic and promising therapeutic axis reshaping the landscape of ageing biology.

In light of these revelations, future research should explore how developmental stages influence mitochondrial-NE communication across diverse cell types and tissues. Understanding the temporal windows during which mitochondrial superoxide exerts its programming effects could inform preventive strategies beginning early in life to maximize cellular healthspan.

Additionally, there is a need to delineate the full spectrum of lipid species modulated by this pathway and how alterations in nuclear membrane lipidomics affect chromatin organization and gene expression patterns linked to cellular senescence. The identification of lipid peroxidation control as a conserved ageing regulator suggests that manipulating membrane lipid profiles could rejuvenate cellular functions impaired during ageing.

Overall, this study heralds a transformative advance in our comprehension of the interconnectedness of mitochondrial metabolism, redox homeostasis, and nuclear integrity. By redefining mitochondrial superoxide as a developmental custodian of nuclear envelope structure through the redox-mediated control of lipid metabolism, it reshapes the conceptual framework of ageing and unveils elegant molecular crosstalk that can be harnessed to promote healthy longevity in humans.

In conclusion, the discovery of a mitochondria-to-nuclear envelope signaling axis mediated by mitochondrial superoxide and lipid metabolic reprogramming marks a pivotal milestone in ageing research. It uncovers an intricate molecular choreography that maintains nuclear envelope integrity and delays cellular ageing via modulation of lipid peroxidation. This insight offers a fresh vantage point from which to view and combat the cellular decline that underpins age-associated diseases, holding transformative potential for the development of novel therapeutic strategies aimed at extending healthspan and mitigating premature ageing syndromes.

Subject of Research: Cellular ageing, mitochondrial function, nuclear envelope integrity, redox signaling, lipid metabolism.

Article Title: Mitochondrial superoxide regulates nuclear envelope integrity and ageing via redox-mediated lipid metabolism.

Article References:
Chen, P.X., Zhang, L., Wu, X. et al. Mitochondrial superoxide regulates nuclear envelope integrity and ageing via redox-mediated lipid metabolism. Nat Metab (2026). https://doi.org/10.1038/s42255-026-01452-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s42255-026-01452-9

The allure of NAD⁺ precursors as anti-ageing interventions originates from their capacity to replenish cellular NAD⁺ pools, thereby ostensibly restoring metabolic balance and enhancing cellular repair mechanisms. In rodent models, supplementation with compounds such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) has been associated with improvements in mitochondrial function, cognitive performance, and lifespan extension. However, human clinical trials investigating the efficacy of NAD⁺ precursor supplements have largely produced modest or equivocal outcomes. These discrepancies underscore the complexity of NAD⁺ metabolism in humans and hint at nuanced, tissue-specific dynamics that diverge from those observed in animal models.

Critically, the quantification of NAD⁺ levels in human tissues remains a formidable challenge, constrained by the invasiveness of sampling techniques and the paucity of longitudinal data. Unlike rodents, where tissue biopsies can be systematically obtained and analyzed, human studies often rely on peripheral blood or limited tissue biopsies, which may not fully capture the systemic and local variations of NAD⁺ status. Moreover, the heterogeneity of human populations, influenced by genetics, lifestyle, diet, and comorbidities, adds layers of variability challenging the interpretation of NAD⁺ dynamics with ageing.

Emerging evidence tentatively confirms an age-associated decline in NAD⁺ in select human tissues such as skeletal muscle and brain, yet this decline is neither universal nor consistent across all studies. The complexity deepens when considering NAD⁺ precursor supplementation, which has shown variable efficacy across different tissues. For instance, some studies report increased NAD⁺ concentrations in skeletal muscle or blood following NR or NMN administration, while others detect minimal or transient changes. This variability raises pivotal questions about the bioavailability, tissue targeting, and metabolic fate of supplemented precursors in humans.

At the molecular level, NAD⁺ functions both as a substrate for enzymes like sirtuins and poly(ADP-ribose) polymerases (PARPs) and as a redox carrier shuttling electrons during metabolic reactions. The balance between NAD⁺ synthesis, consumption, and recycling governs cellular energetic and stress responses. Ageing disrupts this balance by elevating NAD⁺ consumption through DNA damage and chronic inflammation, simultaneously impairing biosynthetic pathways. Understanding how these opposing forces influence NAD⁺ pools in distinct tissues remains fundamental for devising effective therapeutic strategies.

In addition to systemic factors, intracellular compartmentalization of NAD⁺ adds complexity. NAD⁺ pools exist in cytosolic, nuclear, and mitochondrial compartments, each fulfilling unique roles. The crosstalk between these pools and their regulation may vary with age and disease states, potentially explaining the differential responses observed upon supplementation. Current analytical methods often measure total NAD⁺ without resolving compartment-specific dynamics, limiting mechanistic insights.

Clinical trials to date have predominantly focused on relatively healthy older adults, often employing short-duration supplementation and limited dosing regimens. Such parameters may be insufficient to elicit measurable biological effects, especially considering age-related declines in NAD⁺ biosynthetic efficiency and possible alterations in precursor uptake or metabolism. Future studies will need to explore optimized dosing, duration, and combination therapies, as well as stratify participants based on metabolic and molecular biomarkers to identify responders versus non-responders.

Beyond ageing, NAD⁺ metabolism intersects intimately with various pathological conditions, including metabolic syndrome, neurodegenerative diseases, and cardiovascular disorders. The interplay between disease processes and NAD⁺ homeostasis may complicate interpretation of supplementation outcomes. For example, chronic diseases may impose heightened NAD⁺ consumption or impair salvage pathways, necessitating tailored therapeutic approaches. Personalized medicine frameworks incorporating NAD⁺ metabolism profiling could enhance intervention efficacy.

Furthermore, the safety profile of long-term NAD⁺ precursor supplementation warrants thorough investigation. While generally well-tolerated in short-term trials, potential off-target effects, metabolic imbalances, or perturbations of cellular signaling pathways must be carefully scrutinized in larger and extended studies. Regulatory oversight and standardized protocols will be crucial as these compounds gain popularity as nutraceuticals.

Technological advancements in mass spectrometry, imaging, and omics methodologies promise to shed light on the intricate landscape of NAD⁺ metabolism across tissues and disease states. These tools enable quantification of NAD⁺ and related metabolites with high spatial and temporal resolution, providing unprecedented opportunities to elucidate mechanisms underlying NAD⁺ dynamics and to refine supplementation strategies.

In sum, the enthusiasm for NAD⁺ precursor supplementation as a panacea for ageing-related decline is tempered by a nascent and fragmented clinical evidence base. Bridging the translational gap from rodent models to humans demands a concerted effort to conduct comprehensive, multisystem clinical studies integrating molecular, cellular, and physiological endpoints. Such endeavors will clarify the true potential and limitations of NAD⁺-targeted therapies in promoting healthy human ageing.

Ultimately, advancing this field hinges on embracing the biological complexity of NAD⁺ metabolism and recognizing the multifactorial nature of ageing. Integrative research initiatives that factor in genetics, lifestyle, metabolic health, and environmental exposures are essential to devise precision interventions. As the scientific community accelerates towards these goals, NAD⁺ precursor supplementation remains a compelling yet evolving frontier in the quest to decipher and modulate the ageing process.

Subject of Research:
Nicotinamide adenine dinucleotide (NAD⁺) metabolism and its modulation through precursor supplementation in the context of human ageing.

Article Title:
NAD⁺ precursor supplementation in human ageing: clinical evidence and challenges.

Article References:
Vinten, K.T., Trętowicz, M.M., Coskun, E. et al. NAD⁺ precursor supplementation in human ageing: clinical evidence and challenges. Nat Metab (2025). https://doi.org/10.1038/s42255-025-01387-7

Image Credits: AI Generated

In the relentless pursuit to decipher the biological determinants of aging, core body temperature (Tb) emerges as a compelling and long-established variable intersecting with lifespan across diverse species. Recent strides in aging research reveal a complex tapestry whereby lowering Tb consistently correlates with increased longevity, yet the mechanistic underpinnings defy simple thermodynamic or metabolic models traditionally posited. This evolving narrative, propelled by recent data, indicates a sophisticated biological program responding to temperature that encompasses nutrient sensing, proteostasis, epigenetic regulation, and RNA-based mechanisms, repositioning Tb from a mere thermodynamic parameter to a dynamic modulator of cellular and organismal aging.

Historically, frameworks explaining the longevity effects of lowered Tb centered on fundamental physicochemical principles. The prevailing hypothesis posited that reductions in temperature slow down nonenzymatic chemical reactions, decreasing molecular damage accrual, such as the formation of advanced glycation end products. Similarly, it was hypothesized that cooler body temperature diminishes mitochondrial generation of reactive oxygen species (ROS), thereby mitigating oxidative stress—a known contributor to cellular senescence and age-associated decline. Furthermore, models suggested that a reduced metabolic rate accompanying lower Tb conserves cellular resources, delaying the onset of aging phenotypes by minimizing energy turnover and damage from metabolic byproducts.

Contemporary research challenges the sufficiency of these explanations, revealing that the antiaging influence of Tb extends beyond these classical thermodynamic and metabolic tenets. For instance, compelling evidence from invertebrate models demonstrates that cold exposure initiates nuanced molecular responses, involving modulation of nutrient-sensing pathways such as insulin/IGF-1 signaling and target of rapamycin (TOR) pathways—both emblematic regulators of lifespan and metabolic homeostasis. These pathways, finely attuned to environmental cues, suggest that Tb acts as a signaling vector enabling physiological recalibration for survival under cold stress, rather than just passively slowing chemical reactions.

Proteostasis—the maintenance of protein homeostasis—represents another axis through which lowered Tb exerts its survival benefits. Studies in model organisms such as Caenorhabditis elegans reveal that cold stress can enhance the capacity of cellular quality control mechanisms, promoting the folding, trafficking, and degradation of proteins. This facilitates cellular resilience against proteotoxic stressors that typically accumulate with age, mitigating aggregation-prone proteins implicated in neurodegenerative diseases. Moreover, the conformational dynamics of proteins and nucleic acids are finely sensitive to temperature changes, influencing their structural integrity and functional output. Temperature-dependent modulation of protein folding landscapes and nucleic acid stability is no longer perceived as a mere physicochemical consequence but as an active determinant in longevity pathways.

Further evidence underscores the impact of temperature on the function of thermosensitive ion channels, which mediate critical cellular processes including neuronal signaling and metabolic regulation. These channels, responsive to cold stimuli, may mediate downstream transcriptional and posttranslational effects pivotal to longevity programs. Intriguingly, genetic mutations conferring extended lifespan in invertebrates often reveal temperature sensitivity, exemplified by dauer-related mutations in nematodes, underscoring the interplay between genetic regulators of aging and thermal environment.

On the genomic level, the stability of nucleic acid structures—such as base pairing and stem-loop formations in RNA—is profoundly modulated by temperature shifts, impacting RNA metabolism, translational fidelity, and the capacity for adaptive gene expression. These thermodynamic alterations suggest that cold exposure remodels the cellular transcriptome and proteome through mechanisms extending beyond canonical gene regulation to include RNA secondary structure-driven control.

In addition to these molecular layers, epigenetic modifications emerge as a critical interface between temperature and longevity. Temperature fluctuations have been linked to alterations in DNA methylation patterns, histone modifications, and chromatin remodeling, collectively influencing gene expression landscapes that govern aging phenotypes. The modulation of inflammation—a pivotal driver of aging and age-related diseases—is also temperature-responsive, with lower Tb attenuating proinflammatory signaling pathways, thereby contributing to a systemic environment conducive to healthy aging.

On a cellular level, exposure to reduced Tb induces the expression of RNA-binding cold shock proteins which have multifaceted roles in mRNA stability, translation, and cellular stress responses. Cold-sensitive kinases activated under these conditions can orchestrate signaling cascades reprogramming cellular states toward enhanced maintenance and repair capacities. Moreover, temperature modulates RNA splicing, offering an additional layer of posttranscriptional regulation that could reshape protein isoform repertoires to favor longevity.

This compendium of insights culminates in a paradigm shift: lowering core body temperature does not merely retard metabolic or chemical reaction rates but actively engages a complex network of genetic, epigenetic, and proteomic processes tailored to extend healthspan and lifespan. These mechanisms coalesce into a refined biological response, orchestrating survival in fluctuating thermal environments and offering promising vistas for translational interventions.

Looking ahead, vital research directions include elucidating the conserved and species-specific components of temperature-responsive longevity pathways, deciphering the integrative molecular circuits linking Tb to systemic aging phenotypes, and harnessing temperature mimetics—pharmacological or genetic tools that replicate the beneficial effects of lowered Tb without necessitating actual hypothermia. Advances in thermoregulatory biology promise novel approaches to human aging management, positioning temperature modulation as a compelling frontier in geroscience.

Given the ubiquity of temperature as an environmental and physiological variable, these findings forge new frontiers in understanding the intimate dialogue between organismal physiology and aging mechanisms. The prospect of controlled Tb manipulation or mimicking its effects heralds a transformative era where longevity interventions might be engineered with precision, potentially revolutionizing healthcare paradigms for age-related decline.

In summation, the interplay between core body temperature and lifespan unfurls as a multidimensional narrative, far surpassing classical thermodynamics and metabolic intuitions. It beckons a reconceptualization of Tb from a passive modifier to an active, integrative determinant of biological aging. The emergent molecular and cellular insights lay the foundation for innovative therapeutic avenues, bridging fundamental biology with clinical aspirations to foster healthy and prolonged human life.

Subject of Research: Aging, longevity, core body temperature, molecular biology of aging

Article Title: Promoting health and survival through lowered body temperature

Article References: Conti, B., de Cabo, R. Promoting health and survival through lowered body temperature. Nat Aging 5, 740–749 (2025). https://doi.org/10.1038/s43587-025-00850-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s43587-025-00850-0

Keywords: core body temperature, longevity, aging, calorie restriction, nutrient sensing, proteostasis, epigenetics, RNA structure, cold shock proteins, thermosensitive ion channels

Werner syndrome manifests clinically with characteristics typically observed in elderly individuals, including cataracts, osteoporosis, hair thinning, and cardiovascular disease, but with an onset as early as the third decade of life. The WRN gene, which encodes a helicase involved in DNA repair and genome maintenance, plays a protective role in cellular longevity. Its loss of function leads to accelerated cellular senescence and genomic instability. However, the exact mechanisms by which WRN deficiency drives premature aging at the mitochondrial and metabolic level have remained elusive—until now.

This new study reveals that cells lacking functional WRN protein suffer from a significant depletion of mitochondrial nicotinamide adenine dinucleotide (NAD+), a vital coenzyme central to energy metabolism, redox reactions, and mitochondrial health. NAD+ serves as a substrate for key enzymes involved in DNA repair, gene expression regulation, and metabolic adaptation. Deficiencies in mitochondrial NAD+ compromise oxidative phosphorylation, leading to reduced ATP production and enhanced mitochondrial dysfunction, which accelerates cellular aging features observed in WS.

Through comprehensive gene-set enrichment analyses and transcriptomic profiling, the researchers identified that WRN-deficient mesenchymal stem cells (MSCs) exhibit widespread disruptions in metabolic and mitochondrial pathways. Notably, pathways governing NAD+ biosynthesis and salvage were significantly downregulated, suggesting that WRN plays a crucial role in maintaining intracellular NAD+ homeostasis. Intriguingly, treatment with nicotinamide riboside (NR), a precursor molecule that elevates cellular NAD+ levels, robustly rescued many of these metabolic defects within just 24 hours.

NR supplementation not only restored the expression of genes involved in mitochondrial function and proliferation but also mitigated cellular senescence markers in WS-derived MSCs and primary fibroblasts. Senescence-associated β-galactosidase (SA-β-Gal) staining, a gold-standard assay for detecting aging cells, showed a marked decrease in NR-treated WRN-deficient cells, confirming the rejuvenating effect of NAD+ augmentation. Additional assays demonstrated improved nuclear retention of HMGB1, a chromatin-associated protein whose cytoplasmic translocation is a hallmark of senescent cells, further corroborating the anti-senescence potential of NR.

Despite these promising results, the study carefully notes that NAD+ replenishment, while beneficial, did not completely reverse all dysfunctions in WRN-deficient cells. This finding underscores the multifaceted role of the WRN helicase, whose DNA repair and genome stability functions cannot be fully substituted by metabolic intervention alone. Nonetheless, the capacity of NR to partially restore cellular health highlights NAD+ metabolism as a viable therapeutic axis that could be exploited in mitigating premature aging syndromes.

Mechanistically, the interplay between WRN and NAD+ metabolism appears complex, involving coordinated regulation of genes that drive NAD+ biosynthetic pathways. Loss of WRN disrupts this balance, precipitating mitochondrial malfunctions and bioenergetic collapse that accelerate cellular aging. The findings also raise compelling questions about how subcellular NAD+ pools are regulated and distributed, and how these dynamics intersect with DNA repair and longevity pathways.

This work aligns with a growing body of research emphasizing the centrality of NAD+ homeostasis in aging and age-associated diseases such as neurodegeneration, metabolic disorders, and cancer. The ability to pharmacologically modulate NAD+ levels through precursors like NR or nicotinamide mononucleotide (NMN) has sparked considerable interest in developing novel anti-aging therapeutics. The present study strengthens this paradigm by providing concrete evidence that NAD+ augmentation can dampen senescence in the context of a defined genetic premature aging disorder.

Future investigations will be critical in unraveling the precise molecular crosstalk between WRN function, mitochondrial integrity, and NAD+ metabolism. Moreover, studies extending beyond in vitro models into animal systems and clinical settings will be invaluable to evaluate the translational potential of NAD+ boosting compounds for WS patients. If successful, such interventions could herald a new class of therapeutics aimed at mitigating cellular aging and extending healthspan in diverse human populations.

The implications of these discoveries extend far beyond Werner syndrome, offering valuable insight into the universal biological processes that regulate aging and cell vitality. By linking mitochondrial NAD+ depletion to proliferative defects and senescence, this research paves the way for targeted metabolic therapies that may one day combat the fundamental drivers of human aging.

In conclusion, Lautrup, Fang, and colleagues have provided compelling biological evidence that diminished mitochondrial NAD+ is a key contributor to premature cellular aging in WRN-deficient cells. Their work illuminates important pathways susceptible to intervention and offers hope for effective treatments that address the metabolic foundations of premature aging. This landmark study propels the field closer to harnessing metabolic modulation as a legitimate strategy in the fight against age-related decline and genetic aging disorders.

Subject of Research: Cells
Article Title: Decreased mitochondrial NAD+ in WRN deficient cells links to dysfunctional proliferation
News Publication Date: April 2, 2025
Web References: http://dx.doi.org/10.18632/aging.206236
Image Credits: Copyright © 2025 Lautrup et al., distributed under the Creative Commons Attribution License (CC BY 4.0)
Keywords: aging, Werner syndrome, premature aging, NAD+, mitochondria, proliferation